Gil M. Labrucherie
Overview
Gil M. Labrucherie received an average of $3M in total compensation, including $560K in salary, at Nektar Therapeutics from 2008 to 2021.
2021Nektar TherapeuticsChief Operating Officer and Chief Financial Officer
2020Nektar TherapeuticsChief Operating Officer and Chief Financial Officer
2019Nektar TherapeuticsChief Operating Officer and Chief Financial Officer
2018Nektar TherapeuticsSenior Vice President and Chief Financial Officer
2017Nektar TherapeuticsSenior Vice President and Chief Financial Officer
2016Nektar TherapeuticsSenior Vice President and Chief Financial Officer
2015Nektar TherapeuticsSenior Vice President and General Counsel
2014Nektar TherapeuticsSenior Vice President and General Counsel
2013Nektar TherapeuticsSenior Vice President and General Counsel
2012Nektar TherapeuticsSenior Vice President and General Counsel
Source: SEC filings on April 29, 2022, April 30, 2021, April 30, 2019, April 30, 2018, April 29, 2016, April 30, 2015, April 30, 2014, April 30, 2012, and April 29, 2011.
Related executives
We found 20 more executives who work or worked at Nektar Therapeutics.
Howard Robin
Nektar Therapeutics
Chief Executive Officer
Jonathan Zalevsky
Nektar Therapeutics
Senior Vice President and Chief Research and Development Officer
John Northcott
Nektar Therapeutics
Senior Vice President and Chief Commercial Officer
Mark Wilson
Nektar Therapeutics
General Counsel
Jillian Thomsen
Nektar Therapeutics
Chief Accounting Officer
Stephen Doberstein
Nektar Therapeutics
Chief Research and Development Officer
Maninder Hora
Nektar Therapeutics
Senior Vice President Pharmaceutical Development and Chief Technical Operations Officer
John Nicholson
Nektar Therapeutics